Stroke and stroke-like episodes in muscle disease

Open Neurology Journal

Volumn 6, Issue 1, 2012, Pages 26-36

  Finsterer, Josef ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Atrial fibrillation; Cardiomyopathy; Cerebral infarction; Genetics; Ischemic stroke; Melas syndrome; Neuromuscular disorder; Noncompaction; Stroke like episode

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ARGININE; BIOTIN; CARNITINE; CYCLOPHOSPHAMIDE; CYTOCHROME C; DICHLOROACETIC ACID; FLAVINE MONONUCLEOTIDE; GLYCEROL; IDEBENONE; IMMUNOGLOBULIN G; NEUROLEPTIC AGENT; NICOTINE; NORPHENAZONE; PREDNISOLONE; SEDATIVE AGENT; STEROID; SUCCINIC ACID; THIAMINE PHOSPHATE; TOCOPHEROL; UBIQUINONE;

ANXIETY DISORDER; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONGESTIVE CARDIOMYOPATHY; DERMATOMYOSITIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MEGADOSE; EPILEPSY; HEADACHE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART INFARCTION; HUMAN; LEFT VENTRICULAR HYPERTRABECULATION; MUSCLE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOTHERAPY; POLYMYOSITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SEIZURE; STROKE; VASCULITIS;

EID: 84861839657     PISSN: None     EISSN: 1874205X     Source Type: Journal    
DOI: 10.2174/1874205X01206010026     Document Type: Article

References (155)

1. Yatsu FM. Strokes in Asians and Pacific-Islanders, Hispanics, and Native Americans. Circulation 1991; 83: 1471-1472.
2. Kim JH, Lim MK, Jeon TY, et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol 2011; 12: 15-24.
3. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in amulticen-ter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
4. Finsterer J, Stollberger C. Stroke in myopathies. Cerebrovasc Dis 2010; 29: 6-13.
5. Finsterer J. Mitochondrial disorder overlapping with aorto-iliac occlusive disease (Leriche syndrome). Scott Med J 2008; 53: 65-71.
6. Tay SH, Nordli DR Jr, Bonilla E, et al. Aorticrupture in mitochon-drial encephalopathy, lactic acidosis, and stroke-likeepisodes. Arch Neurol 2006; 63: 281-3.
7. Gimenez-Muñoz A, Capablo JL, Alarcia R, Torné L, Errea JM. Intracardiacthrombus and cerebral infarction in a patient with Duchenne muscular dystrophy. J Clin Neuromuscul Dis 2009; 11: 79-80.
8. Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke 2003; 34: 901-908.
9. Atsumi M, Tanaka A, Kawarabayashi T, et al. Cerebral embolism associated with Becker muscular dystrophy-related dilated cardio-myopathy. No to Shinkei 2004; 56: 163-167.
10. Hanajima R, Kawai M. Incidence of cerebral infarction in Duchenne muscular dystrophy. Muscle Nerve 1996; 19: 928.
11. Cook AW, Bird TD, Spence AM, Pagon RA, Wallace JF. Myotonic dystrophy, mitral-valve prolapse, and stroke. Lancet 1978; 1: 335-336.
12. Biller J, Ionasescu V, Zellweger H, Adams HP Jr, Schultz DT. Frequency ofcerebral infarction in patients with inherited neuro-muscular diseases. Stroke 1987; 18: 805-807.
13. Wahbi K, Meune C, Bécane HM, et al. Left ventricular dysfunction and cardiac arrhythmias arefrequent in type 2 myotonic dystrophy: a case control study. Neuromuscul Disord 2009; 19: 468-472.
14. Finsterer J, Stöllberger C, Avanzini M, Rauschka H. Restrictive cardiomyopathy in dermatomyositis. Scand J Rheumatol 2006; 35: 229-232.
15. Nodari S, Triggiani M, Campia U, Manerba A, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011; 57: 870-879.
16. Ikeniwa C, Sakai M, Kimura S, Wakayama T, et al. Two cases of Duchenne muscular dystrophy complicated with dilated cardio-myopathy and cerebral infarction. No To Shinkei 2006; 58: 250-255.
17. Díaz Buschmann C, Ruiz Falcó ML, Tamariz Martel Moreno A, et al. Repeated cerebral infarction in a patient with Duchenne's muscular dystrophy. Rev Neurol 2004; 38: 533-536.
18. Ances BM, Sullivan J, Weigele JB, et al. Stroke associated with Barth syndrome. J Child Neurol 2006; 21: 805-807.
19. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990; 82: 507-513.
20. Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: persistence of isolated myocardial sinusoids. Am J Cardiol 1984; 53: 1733-1734.
21. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction. J Am Soc Echocardiogr 2004; 17: 91-100.
22. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/ noncompaction. Pediatr Cardiol 2009; 30: 659-681.
23. Fazio G, Corrado G, Zachara E, et al. Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagers-town) 2008; 9: 1095-1097.
24. Finsterer J, Stollberger C, Mölzer G, Winkler-Dworak M, Blazek G. Cerebrovascular events in left ventricular hypertrabecula-tion/noncompaction with and without myopathy. Int J Cardiol 2008; 130: 344-348.
25. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction and stroke or embolism. Cardiology 2005; 103: 68-72.
26. Fazio G, Novo G, Visconti C, et al. An unusual cause of cerebral cardioembolism in a 33-year-old man due to ventricular noncom-paction. Neurologist 2009; 15: 51-52.
27. Oduncu V, Akgun T, Erkol A, Mutlu B. Biventricular noncompac-tion presenting with stroke. Eur J Cardiothorac Surg 2008; 33: 737.
28. Sahin S, Karsidag S. An unusual cause of cardioembolic stroke: isolated left ventricular noncompaction. Neurologist 2009; 15: 51.
29. Sir JJ, Lee B, Nah JC, et al. Serious cardioembolic stroke resulting from an overlooked left ventricular noncompaction. South Med J 2008; 101: 969-970.
30. Iizuka T, Goto Y, Miyakawa S, et al. Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci 2009; 278: 35-40.
31. Suwa A, Hirakata M, Kaneko Y, Sato S, Suzuki Y, Kuwana M. Successful treatment of refractory polymyositis with the immuno-suppressant mizoribine: case report. Clin Rheumatol 2009; 28: 227-229.
32. Regan M, Haque U, Pomper M, Pardo C, Stone J. Central nervous system vasculitis as a complication of refractory dermatomyositis. J Rheumatol 2001; 28: 207-211.
33. White DA, Leonard MC. Acute stroke with high-dose intravenous immune globulin. Am J Health Syst Pharm 2007; 64: 1611-1614.
34. Sherer Y, Livneh A, Levy Y, Shoenfeld Y, Langevitz P. Dermato-myositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome. Lupus 2000; 9: 42-46.
35. Kosinski C, Mull M, Lethen H, Töpper R. Evidence for cardioem-bolic stroke in a case of Kearns-Sayre syndrome. Stroke 1995; 26: 1950-1952.
36. Kalashnikova LA, Sakharova AV, Dobrynina LA, et al. Mitochon-drial arteriopathy as a cause of spontaneous dissection of cerebral arteries. Zh Nevrol Psikhiatr Im S S Korsakova 2010; 110 (Suppl 2): 3-11.
37. Matsuishi T, Yano E, Terasawa K, et al. Basilar artery occlusion in a case of Duchenne muscular dystrophy. Brain Dev 1982; 4: 379-384.
38. Morris LK, Cuetter AC, Gunderson CH. Myotonic dystrophy, mitral valve prolapse, and cerebral embolism. Stroke 1982; 13: 93-94.
39. Liang WC, Yuo CY, Liu CY, et al. Novel LMNA mutation in a Taiwanese family with autosomal dominant Emery-Dreifuss muscular dystrophy. J Formos Med Assoc 2007; 106(suppl. 2): S27-S31.
40. Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000; 69: 248-250.
41. Morin C, Dubé J, Robinson BH, et al. Stroke-like episodes in autosomal recessive cytochrome oxidase deficiency. Ann Neurol 1999; 45: 389-392.
42. Furuya H, Sugimura T, Yamada T, Hayashi K, Kobayashi T. A case of incomplete Kearns-Sayre syndrome with a stroke like episode. Rinsho Shinkeigaku 1997; 37: 680-684.
43. Ishikawa N, Tajima G, Ono H, Kobayashi M. Different neurora-diological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia. Brain Dev 2009; 31: 240-243.
44. Anand G, Maheshwari N, Roberts D, et al. X-linked hereditary motor sensory neuropathy (type 1) presenting with a stroke-like episode. Dev Med Child Neurol 2010; 52: 677-679.
45. Kamogawa K, Toi T, Okamoto K, Okuda B. A case of Creutzfeldt-Jakob disease with stroke-like episode as an initial symptom. Nippon Ronen Igakkai Zasshi 2009; 46: 458-461.
46. Scholl-Bürgi S, Haberlandt E, Gotwald T, et al. Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation. Neuropediatrics 2009; 40: 76-81.
47. Wheeler PG, Medina S, Dusick A, Bull MJ, Andreoli SP, Edwards-Brown M. Livedo reticularis, developmental delay and stroke-like-episode in a 7-year-old male. Clin Dysmorphol 1998; 7: 69-74.
48. Broyer M, Tête MJ, Guest G, Berthélémé JP, Labrousse F, Poisson M. Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 1996; 19: 65-75.
49. Finsterer J. Management of mitochondrial stroke-like episodes. Eur J Neurol 2009; 16: 1178-1184.
50. Sartor H, Loose R, Tucha O, Klein HE, Lange KW. MELAS: a neuropsychological and radiological follow-up study. Mitochon-drial encephalomyopathy, lactic acidosis and stroke. Acta Neurol Scand 2002; 106: 309-313.
51. Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003; 61: 1238-1244.
52. Ito H, Mori K, Harada M, et al. Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev 2008; 30: 483-488.
53. Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mito-chondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke 2009; 40: e15-e17.
54. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002; 59: 816-824.
55. Nariai T, Ohno K, Akimoto H, et al. Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome - xenon CT and PET study. Keio J Med 2000; 49(suppl 1): A68-A70.
56. Takahashi S, Tohgi H, Yonezawa H, Obara S, Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 1998; 158: 58-64.
57. Li JY, Hsieh RH, Peng NJ, et al. A follow-up study in a Taiwanese family with mitochondrial myopathy, encephalopathy, lactic acido-sis and stroke-like episodes syndrome. J Formos Med Assoc 2007; 106: 528-536.
58. Klein A, Fasnacht M, Huisman TA, Neuhaus TJ, Martin E, Bolt-shauser E. Siblings with infantile cerebral stroke and delayed mul-tivessel involvement - a new hereditary vasculopathy? Eur J Paedi-atr Neurol 2007; 11: 292-296.
59. Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010; 12: 330-334.
60. Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998; 55: 849-852.
61. Wilichowski E, Pouwels PJ, Frahm J, Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999; 30: 256-263.
62. Iizuka T. Pathogenesis and treatment of stroke-like episodes in MELAS. Rinsho Shinkeigaku 2008; 48: 1006-1009.
63. Takahashi N, Shimada T, Murakami Y, et al. Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci 2005; 329: 265-266.
64. Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006; 32: 359-373.
65. Noguchi A, Shoji Y, Matsumori M, Komatsu K, Takada G. Strokelike episode involving a cerebral artery in a patient with MELAS. Pediatr Neurol 2005; 33: 70-71.
66. Iizuka T, Sakai F, Ide T, Miyakawa S, Sato M, Yoshii S. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS - implication of neurovas-cular cellular mechanism. J Neurol Sci 2007; 257: 126-138.
67. Finsterer J. Treatment of mitochondrial disorders. Eur J Paediatr Neurol 2010; 14: 29-44.
68. Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Ma-tsuishi T. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci 2010; 1201: 104-110.
69. Iizuka T, Sakai F, Endo M, Suzuki N. Response to sumatriptan in headache of MELAS syndrome. Neurology 2003; 61: 577-578.
70. Santa KM. Treatment options for mitochondrial myopathy, en-cephalopathy, lacticacidosis, and stroke-like episodes (MELAS) syndrome. Pharmacotherapy 2010; 30: 1179-1196.
71. DiMauro S, Rustin P. A critical approach to the therapy of mito-chondrial respiratory chain and oxidative phosphorylation diseases. Biochim Biophys Acta 2009; 1792: 1159-1167.
72. Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2006; 1: CD004426.
73. Toribe Y, Tominaga K, Ogawa K, Suzuki Y. Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. No To Hattatsu 2007; 39: 38-43.
74. Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M. Beneficial effect of L-arginine for stroke-like-episode in ME-LAS. Brain Dev 2004; 26: 481-3.
75. Rossi FH, Okun M, Yachnis A, Quisling R, Triggs WJ. Corticosteroid treatment of mitochondrial encephalomyopathies. Neurologist 2002; 8: 313-315.
76. Madej-Pilarczyk A, Kmieć T, Fidziahska A, et al. Progeriacaused by a rare LMNA mutation p.S143F associated with mild myopathy and atrialfibrillation. Eur J Paediatr Neurol 2008; 12: 427-430.
77. Hershberger RE, Cowan J, Morales A. LMNA-Related Dilated Cardiomyopathy. 2008 Jun 12. In: Pagon RA, Bird TC, Do-lan CR, Stephens K, editors. Gene Reviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=dcm-lmna
78. Brauch KM, Chen LY, Olson TM. Comprehensive mutation scanning of LMNA in 268patients with lone atrial fibrillation. Am J Cardiol 2009; 103: 1426-1428.
79. Otomo J, Kure S, Shiba T, et al. Electrophysiological andhisto-pathological characteristics of progressive atrioventricular blockac-companied by familial dilated cardiomyopathy caused by a novel mutation oflamin A/C gene. J Cardiovasc Electrophysiol 2005; 16: 137-145.
80. Yuan WL, Huang CY, Wang JF, et al. R25G mutation in exon 1 of LMNA gene is associated with dilatedcardiomyopathy and limb-girdle muscular dystrophy 1B. Chin Med J (Engl) 2009; 122: 2840-2845.
81. van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 2005; 83: 79-83.
82. Brenner R, Joerg L, Rickli H. Myotonic dystrophy as a potential killer. Acta Cardiol 2009; 64: 567-569.
83. Eroǧlu S, Ozin B, Ozbiçer S, Müderrisoǧlu H. A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibril-lation. Turk Kardiyol Dern Ars 2009; 37: 337-340.
84. Halawa A, Iskandar SB, Brahmbhatt V, Fahrig SA. Atrial flutter and myotonicdystrophy in a male adolescent treated with radiofre-quency catheter ablation. Rev Cardiovasc Med 2007 Spring; 8: 118-122.
85. Stevenson WG, Perloff JK, Weiss JN, Anderson TL. Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiacinvolvement. J Am Coll Cardiol 1990; 15: 292-299.
86. Melberg A, Oldfors A, Blomstrom-Lundqvist C, et al. Autosomal-dominant myofibrillar myopathy with arrhythmogenic right ven-tricularcardiomyopathy linked to chromosome 10q. Ann Neurol 1999; 46: 684-692.
87. Abraham SC, DeNofrio D, Loh E, et al. Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy. Hum Pathol 1998; 29: 876-882.
88. Vernengo L, Chourbagi O, Panuncio A, et al. Desmin myopathy with severe cardiomyopathy in a Uruguayan familydue to a codon deletion in a new location within the desmin 1A rod domain. Neu-romuscul Disord 2010; 20: 178-187.
89. Takahashi M, Nakamura M, Yamaoka Y, Nakano S, Akiguchi I. A case of rigidspine syndrome with congenital cardiac abnormality of sinus venosus defect. Rinsho Shinkeigaku 1995; 35: 204-207.
90. Spinazzi M, Fanin M, Melacini P, Nascimbeni AC, Angelini C. Cardioembolicstroke in Danon disease. Clin Genet 2008; 73: 388-390.
91. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F. McLeodneuroacanthocytosis: genotype and phenotype. Ann Neurol 2001; 50: 755-764.
92. Jung HH, Danek A, Frey BM. McLeod syndrome: a neurohaema-tological disorder. Vox Sang 2007; 93: 112-121.
93. Finsterer J, Ramaciotti C, Wang CH, et al. Cardiac findings in congenital muscular dystrophies. Pediatrics 2010; 126: 538-545.
94. Soliman OI, van der Beek NA, van Doorn PA, et al. Cardiac involvement in adults withPompe disease. J Intern Med 2008; 264: 333-339.
95. Finsterer J. Recurrent pancreatitis as a manifestation of multisystem mitochondrial disorder. Minerva Gastroenterol Dietol 2007; 53: 285-289.
96. Banwell BL, Becker LE, Jay V, Taylor GP, Vajsar J. Cardiac manifestations ofcongenital fiber-type disproportion myopathy. J Child Neurol 1999; 14: 83-87.
97. Celik C, Uysal H, Heper AO, karaoglan B. epidermolysis Bullosa simplex associated with muscular dystrophy and cardiac involvement. J Clin Neuromuscul Dis 2005; 6: 157-161.
98. Sainte-Beuve C, Victor J, Penisson I, Tadei A. Arrhythmia and conductiondefects in polymyositis. Arch Mal Coeur Vaiss 1994; 87: 1241-1245.
99. Altman A, Szyper-Kravitz M, Shoenfeld Y. Colchicine-induced rhabdomyolysis. Clin Rheumatol 2007; 26: 2197-2199.
100. Mahitchi E, Balagué F, Waldburger M. What is your diagno-sis.Myopathy due to hypothyroidism aggravated by amiodarone. Praxis (Bern 1994) 2009; 98: 999-1000.
101. Coppola G, Bützberger S, Greminger P, Schulthess G. Muscle weakness. Praxis (Bern 1994) 2003; 92: 236-240.
102. Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Opin Cardiol 1997; 12: 329-343.
103. Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 2005; 62: 1894-1899.
104. Muller T, Krasnianski M, Witthaut R, Deschauer M, Zierz S. Dilated cardiomyopathy may be an early sign of the C826A Fu-kutin-related protein mutation. Neuromuscul Disord 2005; 15: 372-376.
105. Ben Yaou R, Gueneau L, Demay L, Stora S, Chikhaoui K, Richard P. Heart involvement in lamin A/C related diseases. Arch Mal Coeur Vaiss 2006; 99: 848-855.
106. Fujimori Y, Okimatsu H, Kashiwagi T, et al. Molecular defects associated with antithrombin deficiency and dilated cardiomyopa-thy in a Japanese patient. Intern Med 2008; 47: 925-931.
107. Volpi L, Ricci G, Passino C, et al. Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNAgene duplication. Neuromuscul Disord 2010; 20: 512-516.
108. Hermans MC, Pinto YM, Merkies IS, de Die-Smulders CE, Crijns HJ, Faber CG. Hereditary muscular dystrophies and the heart. Neu-romuscul Disord 2010; 20: 479-492.
109. Bourteel H, Stojkovic T, Cuisset JM, et al. Phenotypic aspects of FKRP-linked muscular dystrophy type 2I in aseries of eleven patients. Rev Neurol (Paris) 2007; 163: 189-196.
110. Murakami T, Hayashi YK, Noguchi S, Ogawa M, Nonaka I, Ta-nabe Y. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 2006; 60: 597-602.
111. Jones KJ, Morgan G, Johnston HT et al. The expanding pheno-type of laminin alpha2 chain (merosin) abnormalities: caseseries and review. J Med Genet 2001; 38: 649-657.
112. Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 2005; 57: 269-276.
113. Wilke A, Schönian U, Herzum M, et al. The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction. Herz 1995; 20: 95-108.
114. Sugimoto S. A novel vacuolar myopathy with dilated cardiomyopa-thy. Autophagy 2007; 3: 638-639.
115. Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M. Clinicopathological features of genetically confirmed Danon disease. Neurology 2002; 58: 1773-1778.
116. DeAdamo P, Fassone L, Gedeon A, Janssen EAM, Bione S, Bol-huis PA. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997; 61: 862-867.
117. Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 2006; 118: e337-e346.
118. Jeren-Strujić B, Jeren T, Thaller N, Zivković Z, Raos V. A case of McLeod syndrome with chronic renal failure. Blood Purif 1998; 16: 336-340.
119. Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B. An X-linked myopathy with postural muscle atrophy and generalizedhypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008; 82: 88-99.
120. Schessl J, Taratuto AL, Sewry C, Battini R, Chin SS, Maiti B. Clinical,histological and genetic characterization of reducing body myopathy causedby mutations in FHL1. Brain 2009; 132: 452-464
121. Muller-Hocker J, Schafer S, Mandel B, Lochmuller H, Pongratz D. Nemaline cardiomyopathy in a young adult: an ultraimmunohisto-chemical study and review of the literature. Ultrastruct Pathol 2000; 24: 407-416.
122. Take C, Asano H, Komatsu A, Miyaji M, Iikuni K, Kowa H. An autopsy case ofdilated cardiomyopathy associated with congenital nemaline myopathy. Nihon Naika Gakkai Zasshi 2008; 97: 413-416.
123. Michalek-Sauberer A, Gilly H. Prophylactic use of dantrolene in a patient withcentral core disease. Anesth Analg 1998; 86: 915-916.
124. Al-Ruwaishid A, Vajsar J, Tein I, Benson L, Jay V. Centronuclear myopathy and cardiomyopathy requiring heart transplant. Brain Dev 2003; 25: 62-66.
125. Manouvrier J, Leys D, Ducloux G, et al. Myocardiopathy disclosing a centronuclear myopathy in an adult. Ann Cardiol Angeiol (Paris) 1986; 35: 557-559.
126. Clarke NF, Smith RL, Bahlo M, North KN. A novel X-linked form of congenitalfiber-type disproportion. Ann Neurol 2005; 58: 767-772.
127. Fujita K, Nakano S, Yamamoto H, et al. An adult case of congenital fiber type disproportion (CFTD) with cardiomyopathy. Rinsho Shinkeigaku 2005; 45: 380-382.
128. Schroder JM, May R, Shin YS, Sigmund M, Nase-Huppmeier S. Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuro-pathol (Berl) 1993; 85: 419-430.
129. Hou JW. Primary systemic carnitine deficiency presenting as recurrent Reye-like syndrome and dilated cardiomyopathy. Chang Gung Med J 2002; 25: 832-837.
130. Bonnet D, Rustin P, Rotig A, et al. Heart transplantation in children with mitochondrial cardiomyopathy. Heart 2001; 86: 570-573.
131. Finsterer J. Dropped head syndrome in mitochondriopathy. Eur Spine J 2004; 13: 652-656.
132. Kleber FX, Park JW, Hübner G, Johannes A, Pongratz D, König E. Congestive heart failure due to mitochondrial cardiomyopathy in Kearns-Sayre syndrome. Klin Wochenschr 1987; 65: 480-486.
133. Finsterer J, Stölberger C, Kopsa W. Noncompaction in myotonic dystrophy type 1 on cardiac MRI. Cardiology 2005; 103: 167-168.
134. Finsterer J, Gelpi E, Stöllberger C. Left ventricular hypertrabecula-tion/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol 2005; 60: 445-448.
135. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003; 42: 2014-2027.
136. Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94: 50-54.
137. Kenton AB, Sanchez X, Coveler KJ, et al. Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alpha-dystrobrevin and FK Binding Protein-12. Mol Genet Metab 2004; 82: 162-166.
138. Thevathasan W, Squier W, Maciver DH, Hilton DA, Fathers E, Hilton-Jones D. Oculopharyngodistal myopathy - A possible asso-ciation with cardiomyopathy. Neuromuscul Disord 2011; 21: 121-125.
139. Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003; 108: 2672-2678.
140. Finsterer J, Schoser B, Stöllberger C. Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabecula-tion/non-compaction. Acta Cardiol 2004; 59: 453-456.
141. Corrado G, Checcarelli N, Santarone M, Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006; 105: 142-145.
142. Münkle T, Kaufmann H, Keim M. Non-compaction cardiomyopa-thy: A rareechocardiographic diagnosis. Dtsch Med Wochenschr 2010; 135: 639-642.
143. Mello RP, Szarf G, Nakano E, Dietrich C, Cirenza C, Paola AA. Noncompaction of the myocardium, Chagas' disease and dysfunction: a case report. Arq Bras Cardiol 2010; 95: e4-e6.
144. Stöllberger C, Finsterer J, Sodeck GH, Grassberger M, Zimpfer D. Stroke from noncompaction overlooked by echocardiography. Int J Cardiol 2010; 148: 357-358.
145. Vatthyam RK, Bates JR, Waller BF. Acute cardiac and neurologic decompensation in a high school athlete. J Am Soc Echocardiogr 2009; 22: 1420.e1-e3.
146. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Electrocardio-graphic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Am J Cardiol 2009; 104: 984-989.
147. Stanton C, Bruce C, Connolly H, et al. Isolated left ventricular non-compaction syndrome. Am J Cardiol 2009; 104: 1135-1138.
148. Baez-Escudero J, Pillai M, Nambi V, Dokainish H. Comprehensive contrast and 3-dimensional echocardiographic imaging of left ventricular noncompaction cardiomyopathy. Eur J Echocardiogr 2008; 9: 156-157.
149. Finsterer J, Stöllberger C, Feichtinger H. Noncompaction and endocarditis in suspected mitochondrial disorder. Int J Cardiol 2008; 123: e45-e47.
150. Nakajima M, Hirano T, Doi H, Uchino M. Stroke and ventricular dysfunction in a patient with isolated left ventricular noncompac-tion. Intern Med 2007; 46: 1251-1254.
151. Celebi AS, Gulel O, Cicekcioglu H, Celebi OO, Ulusoy V. Isolated noncompaction of the left ventricular myocardium complicated by thromboembolic cerebrovascular accident in a patient with essential thrombocythemia. Int J Cardiol 2008; 128: e22-e24.
152. Fernández Sánchez LJ, Pérez González R, Guasch Arévalo E, Martín Reyes R, Gilsanz Rodríguez F. Perioperative treatment of a pregnant woman with recent cerebral infarction secondary to non-compaction cardiomyopathy. Rev Esp Anestesiol Reanim 2006; 53: 661-664.
153. Walpot J, Klazen C, Sorgedrager J, Hoevenaar M, den Braber J. Isolated ventricular noncompaction in a patient with stroke. Echo-cardiography 2005; 22: 690-692.
154. Hasçelik S, Yalnizoǧlu D, Kafali G, et al. Stroke owing to non-compaction of myocardium. J Child Neurol 2003; 18: 437-439.
155. Ohshita T, Oka M, Imon Y, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000; 42: 651-656.